Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Precision Allograft Solutions is a biotechnology company focused on the processing and distribution of human tissue allografts for regenerative medicine. The company provides a specialized portfolio of products used in orthopedic, spine, sports medicine, and wound care procedures to facilitate healing and structural repair. In 2015, the company was acquired by Vivex Biologics, integrating its processing expertise into Vivex's broader regenerative medicine platform. Their offerings include advanced bone matrix, skin substitutes, and connective tissue grafts designed to improve surgical outcomes and patient recovery times.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Precision Allograft Solutions.